A molecular biologist and biophysicist by training, John is a Lead Member of the firm’s Health Care Practice and a topic expert on R&D innovation, gene and cell therapy, and gene editing. John has served a variety of healthcare clients across the industry, including biopharmas, CROs, life science players, and payers. In the past 5 years, John has focused his efforts on biopharma players, where he helps his clients stay at the leading edge of innovation within an ever changing scientific, competitive, and policy environment. He has experience across all functional verticals within biopharma, with deep expertise in R&D and corporate strategy, covering a range of topics including growth strategy, innovation landscaping / M&A scan, portfolio review, digital strategy, LOE planning, operational improvement, and large scale change (post-merger integration, divestiture, restructuring / transformation).His recent case experience includes:- Developed the 10 year growth strategy for a top-5 biopharma player- Assessed next generation cell therapy technology landscape for a leading biotech- Implemented a portfolio assessment framework and process for a top-5 biopharma player- Developed the digital R&D strategy for a leading specialty biopharma player- Supported LOE planning for a $4B product covering Commercial and R&D levers for a leading biotech- Redesigned and implemented a new asset governance model for a leading biopharma player- Improved R&D productivity at a top-5 biopharma player through operational, cultural, and organizational interventions- Redesigned the operating model and key processes for the clinical development, clinical operations, regulatory affairs, and CMC divisions of a leading specialty biopharma player- Supported post-merger integration in a >$50B biopharma M&A focusing on organizational integration of the R&D divisions- Supported divestiture planning for a leading specialty biopharma, focusing on regulatory compliance and MAA transfers

Applied super-resolution imaging (STORM) to investigate the structure and function of telomere DNA and XIST RNA.

Dissertation on dissecting the structure and function relationship of telomerase and telomere using novel single-molecule imaging methods

Spring 2010, MCB156: Structural Biology of the Flow of Information in the Cell-Led weekly discussion section-Authored and graded original problem sets-Coordinated lab facility tours for students -Mentored students in career choicesFall 2009, LS1a: Freshman Introductory Biology-Led weekly discussion sections and lab exercises-Advised freshman on concentration choice-Authored recommendations on behalf of students applying for summer jobs-Awarded Certificate for Distinction in Teaching (given to top 10% of all teaching fellows University-Wide)Spring 2008: MCB 56: Biophysical and Chemical Properties of Macromolecules-Led weekly discussion section-Authored and graded original problem sets-Mentored students in career choices

One of 24 Ph.D. candidates in greater Boston area selected to participate (out of over 120 applicants)-Interacted extensively with BCG consultants and learned about the consulting experience and industry/function specific practices-Worked in a team of six participants and two BCG consultants on a mock case to devise turnaround strategy for a consumer good company-Performed quantitative analysis on profit and loss statement, interviewed key members of C-level executives, gave final presentation